LYMPHOMA, LARGE-CELL, ANAPLASTIC
Clinical trials for LYMPHOMA, LARGE-CELL, ANAPLASTIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, LARGE-CELL, ANAPLASTIC trials appear
Sign up with your email to follow new studies for LYMPHOMA, LARGE-CELL, ANAPLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One drug, many cancers: trial targets tumors by genetic fingerprint
Disease control OngoingThis study is testing a drug called entrectinib for people with advanced solid tumors that have specific genetic changes (NTRK, ROS1, or ALK gene rearrangements). It's a 'basket trial,' meaning it groups patients by their tumor's genetic type rather than where the cancer started …
Matched conditions: LYMPHOMA, LARGE-CELL, ANAPLASTIC
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
First-in-Human trial tests experimental drug for Tough-to-Treat blood cancers
Disease control OngoingThis is the first study testing a new experimental drug called PF-08046044/SGN-35C in people with advanced lymphoma that has returned or stopped responding to standard treatments. The trial will enroll 57 adults with specific types of lymphoma to determine the safest dose, unders…
Matched conditions: LYMPHOMA, LARGE-CELL, ANAPLASTIC
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC